强化英夫利昔单抗诱导治疗类固醇难治性急性严重溃疡性结肠炎——作者的答复

IF 30.9 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Lancet Gastroenterology & Hepatology Pub Date : 2024-12-11 DOI:10.1016/s2468-1253(24)00382-0

Christopher F D Li Wai Suen, Matthew C Choy, Danny Con, Peter De Cruz

引用次数: 0

摘要

没有抽象的

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis – Authors’ reply

No Abstract

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Lancet Gastroenterology & Hepatology Medicine-Hepatology

CiteScore

50.30

自引率

1.10%

发文量

期刊介绍： The Lancet Gastroenterology & Hepatology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The Lancet Gastroenterology & Hepatology publishes papers that reflect the rich variety of ongoing clinical research in these fields, especially in the areas of inflammatory bowel diseases, NAFLD and NASH, functional gastrointestinal disorders, digestive cancers, and viral hepatitis.